Controlling viral immuno-inflammatory lesions by modulating aryl hydrocarbon receptor signaling

63Citations
Citations of this article
31Readers
Mendeley users who have this article in their library.

Abstract

Ocular herpes simplex virus infection can cause a blinding CD4 + T cell orchestrated immuno-inflammatory lesion in the cornea called Stromal Keratitis (SK). A key to controlling the severity of SK lesions is to suppress the activity of T cells that orchestrate lesions and enhance the representation of regulatory cells that inhibit effector cell function. In this report we show that a single administration of TCDD (2, 3, 7, 8- Tetrachlorodibenzo-p-dioxin), a non-physiological ligand for the AhR receptor, was an effective means of reducing the severity of SK lesions. It acted by causing apoptosis of Foxp3 - CD4 + T cells but had no effect on Foxp3 + CD4 + Tregs. TCDD also decreased the proliferation of Foxp3 - CD4 + T cells. The consequence was an increase in the ratio of Tregs to T effectors which likely accounted for the reduced inflammatory responses. In addition, in vitro studies revealed that TCDD addition to anti-CD3/CD28 stimulated naïve CD4 + T cells caused a significant induction of Tregs, but inhibited the differentiation of Th1 and Th17 cells. Since a single TCDD administration given after the disease process had been initiated generated long lasting anti-inflammatory effects, the approach holds promise as a therapeutic means of controlling virus induced inflammatory lesions. © 2011 Veiga-Parga, et al.

Cite

CITATION STYLE

APA

Veiga-Parga, T., Suryawanshi, A., & Rouse, B. T. (2011). Controlling viral immuno-inflammatory lesions by modulating aryl hydrocarbon receptor signaling. PLoS Pathogens, 7(12). https://doi.org/10.1371/journal.ppat.1002427

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free